Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Specimen Handling 289Magnetic Resonance Spectroscopy 240pembrolizumab 223Carboplatin 183Biopsy 154Cyclophosphamide 148Cisplatin 145Paclitaxel 129Nivolumab 124Gemcitabine 114Bevacizumab 110Radiotherapy 87Dexamethasone 85Pemetrexed 81atezolizumab 78fludarabine 76Fluorouracil 75Doxorubicin 74Docetaxel 72Leucovorin 69Rituximab 68Radiation 68Oxaliplatin 66Prednisone 65venetoclax 64durvalumab 60Vincristine 59Cetuximab 56130-nm albumin-bound paclitaxel 56Immunoglobulin G 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngectomy × 30 days × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡